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Abstract 
Introduction: The spread of multidrug-resistant (MDR) strains of 
Mycobacterium tuberculosis has become a major public health concern as 
these bacteria often cause incurable disease, even when expensive second- 
and third-line drugs are available. 
Objectives: This study aimed to identify M. tuberculosis among suspected 
tuberculous patients in Khartoum State by using conventional methods also 
to identify rifampicin and isoniazid resistant M. tuberculosis by amplifying 
(rpo B and katG,kasA) genes  respectively, using polymerase chain reaction 
(PCR).  
 Method: Verbal concent of patients participated in the current study was 
taken from every participant and then epidemiological data were collected. 
Two hundred and fifty sputum samples were collected from suspected 
tuberculosis patients. Direct smears were performed using Ziehl- Neelsen 
stain, then all positive sputum samples were inoculated on Lowenstein 
Jensen medium and incubated aerobically at 37°C. Selected biochemical 
tests were performed to all Mycobacteria spp, Drug sensitivity testing were 
performed to all isolates,IS6110 primers were used  to confirm the 
Mycobacteria tuberclosis type and Polymerase Chain Reaction was used for 
all species to identify resistant genes to Rifampicin, (rpoB gene) and 
isoniazid (katG and kasA genes).    
Results: The results of ZN showed that 91 isolates (36.4%) were positive 
for AFB, and 83(91.2%) of them showed growth of mycobacteria spp.on the 
other hand 159 isolates (63.6%) were negative, and 40 (25.1%) of them 
showed growth of mycobacteria.  
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According to the results of biochemical tests all strains were identified as 
Mycobacterium tuberculosis complex and concordant results were obtained 
by molecular technique using IS6110. 
One hundred twenty threeclinical isolates were subjected to drug 
susceptibility testing  using proportion method . 45/123 (18%) were MDR, 
45 (18%) were sensitive to all 1st line antituberculous drugs, 18(7.2%) were 
resistant to streptomycin, and 15(6%) showed triple resistance to isoniazid, 
ethambutol and streptomycin.   
Forty five resistant isolates were subjected to PCR searching for rifampicin 
resistance genes. The results showed the presence of expected mutant genes 
in 43(95.5%) of rifampcin resistant, while isoniazid resistance gene were 
found in 42(93.3%) of KatG genes and 1(2.2%) due to kas gene only while 
other 4(8.8%) isolates harbour kasA and katG genes in same strains that 
have two points of mutation.  
Conclusion and recommendation: The study revealed that the molecular 
technique was less sensitive than conventional technique in detection of 
multidrug resistance. However molecular technique is not time consuming, 
rapid, reproducible and it may replace conventional methods in the future  
due to low sensitivity of Ziehl- Neelsen stain, and the long time consumed in 
culture and drug sensitivity test. It also represents rapid tools for diagnosis 
and detection of mutation to drugs.  From this study it is clear that MDR TB 
is a serious problem in Sudan .that needs special attention from the health 
authorities.   
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Chapter One 
Introduction and Objectives 
Introduction 
    Tuberculosis is one of the leading infectious diseases in the world and is 
responsible for more than 2 million deaths and 8 million new cases annually 
(Soini and Musser, 2001). Because of the slow growth rate of the causative 
agent Mycobacterium tuberculosis, isolation, identification, and drug 
susceptibility testing of this organism and other clinically important 
mycobacteria can take several weeks or longer (Soini and Musser 2001). 
There have been increasing numbers of reports of infections caused by 
mycobacteria other than M.tuberculosis (MOTT), especially in association 
with human immunodeficiency virus infection (Kim et al 1998).  
 Tuberculosis occurs in at least one third of HIV –positive individuals. 
Twenty four million HIV-positive individuals were reported world 
wide,with 95% in developing countries.  Up to (8) million were reported to 
be co- infected with TB and HIV globally. (Harri et al 1998)   
 During the past years, many molecular methods have been developed for 
direct detection, species identification, and drug susceptibility testing of 
mycobacterium. These methods can potentially reduce the diagnostic time 
from weeks to days (Soini and Musser 2001). 
Clinically important resistance to medications is always a man-made 
problem. 
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Because large populations of tuberculosis micro-organisms always contain 
some mutants naturally resistant to medications, a substantial population of 
resistant micro-organisms is always selected when a single medication is 
used to treat a T.B patient. This occurs because only the micro-organisms 
susceptible to the medications are killed, leaving the resistant micro-
organisms to multiply. When the microorganisms in a patient are resistant to 
all but one of the medications given to that patient, the treatment has the 
same result as when a single medication is given alone. There are two 
important types of resistance to medications in tuberculosis micro-
organisms: 
– Acquired or secondary resistance is due to incorrect treatment; for 
Instance, treatment with a single powerful medication in patients with smear 
positive pulmonary tuberculosis (this is sometimes referred to as 
“monotherapy”), or administration of powerful medications to apatient 
harbouring tuberculosis micro-organisms resistant to all but one of the 
medications which the patient is given (this phenomenon is sometimes 
referred to as “effective monotherapy”). 
– Primary resistance occurs when a patient develops tuberculosis after being 
infected by astrain from a patient who has resistant micro-organisms. 
micro-organisms with resistance to at least the two most important 
medications,isoniazid and rifampicin, are termed “multidrug-resistant”.  
(Donald et al 2000) 
Most cases of multi-drug resistance arise from a mixture of physician error 
and patient non-compliance during treatment of susceptible TB. The extent 
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and burden of MDR-TB varies significantly from country to country and 
region to region. As with TB itself, the overwhelming burden of MDR-TB is 
in high-burden resource-poor countries (Ormerod 2005). 
XDR-TB is the abbreviation for extensively drug-resistant tuberculosis. The 
micro-organisms resistance to at least isoniazid and rifampicin plus any 
fluoroquinolone and at least one injectable second line drugs. In many 
countries, the wide use of the standard short-course regimen has led to an 
increasing incidence of multi-drug-resistant (MDR) tuberculosis (TB), 
Significantly high rates of MDR-TB were observed in some parts of the 
world, not only among previously treated TB patients, due to poor case 
management, but also among new cases due to transmission in the 
community (Kim 2005). 
Multi-drug-resistant tuberculosis (MDR TB) has been documented in nearly 
90 countries and regions worldwide; 424. 203 cases of MDR TB were 
estimated to have occurred in 2004, which is 4.3% of all new and previously 
treated TB cases. The diagnosis depends on confirming the drug 
susceptibility pattern of isolated organisms, which is often only possible in 
resource-rich settings. The treatment of MDR is required for at least 12 and 
possibly more than 24 months, and that less effective and more toxic second-
line drugs have to be used (Ormerod 2005).  
Rapid diagnosis and treatment are important for preventing transmission of 
Mycobacterium tuberculosis. However, the diagnosis of tuberculosis 
continues to pose serious problems, mainly because of difficulties in 
differentiating between patients with active tuberculosis and those with 
healed lesions, normal Mycobacterium bovis BCG (Bacillus Calmette 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
4 
 
Guerin) vaccinated individuals, and unvaccinated Manteux test positives. 
Physicians still rely on conventional methods such as Ziehl-Neelsen (ZN) 
staining, fluorochrome staining, sputum culture, gastric lavage, and other 
non-traditional methods. (Garg et al 2003) Although the tuberculin test has 
aided in the diagnosis of tuberculosis for more than 85 years, its 
interpretation is difficult because sensitization with non-tuberculous 
mycobacteria leads to false-positive tests (Garg et al 2003). There have been 
numerous unsuccessful attempts to develop clinically useful serodiagnostic 
kits for tuberculosis. A number of proteinaceous and nonprotein antigens 
(such as acyltrehaloses and phenolglycolipids) have been explored from time 
to time for the development of such assays but they have not proved to be 
clinically useful (Garg et al 2003). It has been difficult to develop an ELISA 
utilizing a suitable antigen because M. tuberculosis shares a large number of 
antigenic proteins with other microorganisms that may or may not be 
pathogenic. With the advent of molecular biology techniques . there have 
been significant advances in nucleic acid based amplification and 
hybridization, which are helping to rectify existing flaws in the diagnosis of 
tuberculosis. The detection of mycobacterial DNA in clinical samples by 
polymerase chain reaction (PCR) is a promising approach for the rapid 
diagnosis of tuberculous infection. However, the PCR results must be 
corrected for the presence of inhibitors as well as for DNA contamination 
(Garg et al 2003). 
 Rationale 
The emergence of drug-resistant strains of Mycobacterium tuberculosis 
(MTB) is an increasing problem in developed and developing countries 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
5 
 
alike. Today rifampin (RIF) and isoniazid (INH) are important components 
of effective multidrug therapy and prophylaxis for M. tuberculosis 
infections. However, widespread use of these agents and failure of patients 
to complete prescribed treatment have led to the emergence of RIF- and 
INH-resistant strains. ( Frieden et al 1993, Heym et al 1994) 
The detection of resistant M. tuberculosis strains is generally performed by 
conventional susceptibility assays which require the isolate to be cultured in 
the presence of the different drugs. This usually delays in the detection of 
resistance. Thus methods that guarantee the early detection of resistant M. 
tuberculosis strains are required in order to avoid delays in the initiation of 
effective therapies and to prevent transmission of multidrug-resistant (MDR) 
strains. 
The molecular basis of resistance to anti-TB drugs is now becoming clearer. 
More than 95% of RIF-resistant strains are associated with mutations within 
an 81-bp region of the rpoB gene (Ohno et al1997) , Characterization of the 
rpoB gene (a region responsible for synthesis of beta-subunit of RNA 
polymerase) in E.coli demonstrated that rifampin (RIF) specifically interacts  
with the subunit of RNA polymerase, thereby hindering transcription and 
elongation .(Jin  et al1988) 
 Between 60 to 70% of the INH-resistant strains encode mutations in KatG. 
These findings have led to the development of different genotypic 
approaches to the more rapid prediction of resistance in M. tuberculosis, 
especially to RIF and INH. Our aim was to investigate the prevalence of 
resistance of MTB isolates to INH and RIF in the region and to apply PCR 
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for the detection of resistant strains and compare the sensitivity of the 
technique to conventional MIC method .(Felmlee et al1995,Torres et al 
2000) 
Molecular techniques are used to identify mutations in the rpoB gene, KatG 
and kasA gene. The commercially available kits can discover rifampicin  
and isoniazed resistance with 95% sensitivity, using the standard phenotypic 
method as the gold standard. The conventional tuberculosis drug 
susceptibility tests are sensitive and specific, but they are not rapid. 
Molecular amplification techniques are able to potentially reduce the 
diagnostic turnaround time from weeks to days, which acquire a greater 
relevance under special circumstances (Paramasivan 2006).     
Objectives 
 General objective  
- Detection of mutation of(rpoB) gene to  rifampin and (katG and kasA) 
gene to isonizid  resistant to Mycobacterium tuberculosis isolated from 
tuberculosis patients using conventional method and PCR technique 
- comparing the finding of PCR with conventional method. 
 Specific Objectives 
· To isolate and identify the Mycobacterium tuberculosis from 
suspected individuals.  
· To identify MDR-TB by using conventional method.  
· To amplify the rpoB gene, katG and kasAgene among clinical isolate  
· establish a suitable method for extraction MTB DNA from the isolate.   
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· To investigate the performance and feasibility of PCR technique in 
diagnosis of TB in comparison with other conventional method 
· To compare the rate resistance determined by PCR to that determined 
by the conventional method 
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Literature Review 
1. Genus Mycobacterium 
1.1 Definition and taxonomy 
Mycobacteria belong to the family Mycobacteriaceae, the genus 
Mycobacterium is non-motile and non-sporulated rods. They are grouped in 
the suprageneric rank of actinomycetes that, unusually, have a high content 
(61-71 %) of guanine plus cytosine (G+C) in the genomic deoxyribonucleic 
acid (DNA) (Brennan, and Draper 1994). 
Mycobacterium is characterized by possessing elevated lipid content, most 
notably a high level of waxes called mycolic acids. These mycolic acids are 
responsible for the organism being resistant to decolonization by acid 
alcohols. These cells are referred to as being acid-fast and often appear as 
beaded rods when stained with an acid-fast stain such as the Ziehl-Neelsen 
or modified Kinyoun stains( Goldman and Green 2009). By virtue of this 
acid-fast characteristic, mycobacterium can be distinguished from other 
genera. Another important feature of these organisms is that they grow more 
slowly than most other human pathogenic bacteria because of their 
hydrophobic cell surface. Because of this hydrophobicity, organisms tend to 
clump, so that nutrients are not easily allowed into the cell. Growth is slow 
or very slow, with colonies becoming visible in 2 to 60 days at optimum 
temperature ( Forbes et al 2007 ). 
   The genus Mycobacterium consists of organisms that are true pathogens, 
opportunistic pathogens, and saprophytes (Goldman and Green2009). 
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Currently, there are more than 100 recognized or proposed species in the 
genus Mycobacterium (Primm et al 2004). 
These species produce a spectrum of infections in humans and animals 
ranging from localized lesions to disseminated disease. Although some 
species cause only human infections, others have been isolated from a wide 
variety of animals. Many species are also found in water and soil ( Forbes et 
al 2007 ). 
For most part, mycobacteria can be divided into two major groups based on 
fundamental differences in epidemiology and association with disease: those 
belonging to the Mycobacterium tuberculosis complex (M. tuberculosis, M. 
bovis, M. africanum and M.microti ) and those referred to as nontuberculous 
mycobacteria (NTMs) ( Forbes et al 2007 ).  
The term complex is frequently used to describe two or more species whose 
distinction is complicated and of little or no medical importance ( Shinnick 
and Good 1994). 
 The M. tuberculosis complex consists of four species: M. tuberculosis, M. 
bovis, M. africanum, and M. microti. M. bovis is found in cattle but can 
cause a tuberculosis-like illness in humans.  
 An attenuated strain of M. bovis, M. bovis BCG, is used as a vaccine to 
protect against acquiring tuberculosis. M. africanum also causes human 
tuberculosis while M. microti is found in rodents (Goldman and Green 
2009). All species are capable of causing tuberculosis. It should be noted 
that species identification may be required for epidemiologic and public 
health reasons. Organisms belonging to the M. tuberculosis complex are 
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considered slow-growers, and colonies are non-pigmented. ( Forbes et al. 
2007 ). 
1.2 History of tuberculosis 
Girolamo and Fracastoro, (1546) explained the contagious nature of TB, 
they pointed out that bed sheets and clothing could contain contagious 
particles that were able to survive for up to two years. The word “particles” 
may have alluded to chemicals rather than to any kind of living entity. In 
1720, the English physician Benjamin Marten introduce ''A New Theory of 
Consumptions'' and he, reported that TB could be caused by “minute living 
creatures", which, once they had gained entry to the body, could generate the 
lesions and symptoms of phthisis. He further stated that consumption may be 
caught by a sound person by lying in the same bed, eating and drinking or by 
talking together so close to each other as to “draw in part of the breath a 
consumptive patient emits from the lungs In 1865, the French military 
doctor Villemin (1827-1892) demonstrated that consumption could be 
passed from humans to cattle and from cattle to rabbits. On the basis of this 
revolutionary evidence, he postulated that a specific microorganism caused 
the disease. At this time William Budd (1811-1880) also concluded from his 
epidemiological studies that TB was spread through society by specific 
germs. On the evening of March 24, 1882, in Berlin, before a skeptical 
audience composed of Germany's most prominent men of science from the 
Physiological Society, Koch (1843-1910) made his famous presentation Die 
Aetiologie der Tuberculose. Using solid media made of potato and agar, 
Koch invented new methods of obtaining pure cultures of bacteria. His 
colleague Petri (1852-1921) developed special flat dishes (Petri dishes), 
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which are still in common use, to keep the cultures. Koch also developed 
new methods for staining bacteria, based on methylene blue, a dye 
developed by Ehrlich (1854-1915), and counterstained with resurin. He 
wrote in the paper that followed his dramatic presentation that March 
evening (Koch1882). 
He concluded saying that “the bacilli present in tuberculous lesions do not 
only accompany tuberculosis, but rather cause it. These bacilli are the true 
agents of tuberculosis” (Kaufmann and Schaible 2005). 
1.3 Microscopic morphology 
    The microscopic appearance does not allow the differentiation of the 
pathogenic agents of TB, mainly M. tuberculosis, from other mycobacteria 
although some characteristics may be indicative. In smears stained with 
carbol fuchsin or auramine and examined under light microscope, the 
tubercle bacilli typically appear as straight or slightly curved rods. 
According to growth conditions and age of the culture, bacilli may vary in 
size and shape from short coccobacilli to long rods. A typical curved shape 
has been described for M. microti (Soolingen 1997). The dimensions of the 
bacilli have been reported to be 1-10 µ m in length (usually 3- 5 µ m), and 
0.2-0.6 µ m in width. Therefore, the length of the microorganism is 
comparable to the diameter of the nucleus of a lymphocyte (Chauhan 2006). 
Unlike some fast growing mycobacteria and other actinomycetales, M. 
tuberculosis is rarely pleomorphic, it does not elongate into filaments, and 
does not branch in chains when observed in clinical specimens or culture. In 
the experimental macrophage infection, intracellular bacilli were described 
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as being significantly elongated compared to broth-grown bacilli and, 
remarkably, to display bud-like structures (Chauhan 2006). 
When numerous and actively multiplying, the bacilli are strongly acid fast 
and show an evident and distinctive tendency to form hydrophobic bundles. 
Free bacilli can also be seen, though, especially at the border of the swarms. 
In unlysed host tissue, the bacilli are more numerous within the phagocytic 
cells (Palomino et al 2007). 
Once the disease has been controlled, dying bacilli become sparser, often 
faintly and unevenly colored, due to partial loss of the internal contents. Of 
course, irregular staining may also be the consequence of technical 
defectiveness of dyes or staining procedures (Palomino e t al2007). 
The light microscope examination cannot resolve the internal structures of 
the tubercle bacillus with the exception of some intracellular lipid vacuoles 
appearing as unstained spherules at regular intervals inside the bacilli and 
deposits of lipophilic material that might have a storage function (Garton 
2002). Despite considerable efforts, a more subtle resolution of the ultra 
structure of the bacillus has not been achieved. This is probably due to 
technical problems arising from biosafety, from the minute size of the 
bacilli, and from the large amounts of complex lipids existing in their wall. 
With electron microscopy, some inner dense granules can be identified. 
They are believed to consist of polyphosphate and might be an energy store 
in the cell and also the site of oxidation-reduction reactions. (Draper1982 
and Brennan1994) .In sections of the cell, the plasma membrane is seen to 
proliferate into vesicular or laminated internal bodies that might supply 
metabolic activities. Ribosomes, DNA filaments and radial bands, the latter 
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postulated to be remaining scars of cell division, have also been described 
(Draper 1982 and Brennan 1994). 
Recently, the initiation of septum formation prior to division was clearly 
evidenced by tagging the mid-cell rings with green fluorescent protein 
(Chauhan 2006). Also, impressive images of the surface of M. bovis BCG 
were obtained by atomic force microscopy (Verbelen 2006). 
1.4 Cell wall structure 
MTB is an aerobic, non–spore forming, non-motile, pleomorphic bacilli that 
is typically 1 to 5 µ m long and 0.2 to 5 µ m wide (Starke 2004). Its 
generation time is 15 to 20 h; so, visible growth takes 3 to 6 weeks on solid 
media (Haas 2000). The mycobacterial cell wall is composed of superficial 
lipids (e.g., cord factor), mycolic acids, arabinogalactan, peptidoglycan, and 
lipoarabinomannan. The cell wall confers shape, size, protection against 
osmotic pressure, and probably protects the plasma membrane from 
deleterious molecules in the cellular environment (Starke 2004). The cell 
wall components of mycobacteria determine their most prominent feature: 
resistance to acid alcohol. Despite staining with decolorizing agents 
containing 95% ethyl alcohol–3% hydrochloric acid, carbol fuchsin cannot 
be readily removed. Mycobacteria are not classified as either Gram-positive 
or Gram-negative. They are commonly referred to as acid-fast bacilli (AFB) 
(Geo et al 2001).  
This important feature of MTB allows differential staining in contaminated 
specimens like sputum. Polysaccharides in the MTB and Gram-positive 
bacteria cell walls are similar; however, Mycobacterium cell wall contains 
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lipid but Gram-positive bacteria have proteins in their cell wall (Portaels 
1995). 
Mycosides including mycolic acids (long-chain fatty acids C78–C90), 
waxes, and phosphatides are in the exterior surface of the MTB cell 
envelope. In the cell wall, the mycolic acids are largely bound to 
peptidoglycan by phosphodiester bridges and to arabinogalactan by 
esterified glycolipid linkages. The agglutination serotype of strain and 
colony morphology is related to the mycosides (McMurray 2000).  Another 
important cell component of mycobacteria is cord factor (trehalose 6, 
6_dimycolate) that is thought to correlate with virulence. Cord factor may 
cause chronic granulomas and inhibits migration of leukocytes (Geo et al 
2001). 
1.5 Acid fastness 
Unlike gram-negative bacteria, mycobacteria do not have an additional 
membrane in the outer layers of the cell wall. They are structurally more 
closely related to gram positive bacteria . However , mycobacteria do not fit 
into the gram-positive category as the molecules attached to the cell wall are 
distinctively lipids rather than proteins  or polysaccharides .Frequently ,they 
do not retain crystal violet and appears as ‘ghost” after gram staining . The 
waxy cell wall of mycobacteria is impermeable to aniline and other 
commonly used dyes unless these are combined with phenol (Barrera,2007). 
To discover the causative agent of TB, Koch (1882) developed a specific 
staining process using alkaline dyes. Soon after, Ehrlich discovered the acid 
fastness of tubercle bacillus, which has been the prominent characteristic of 
mycobacteria up to now. The expression, acid fastness, describes the 
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resistance of certain microorganisms to decolorization with acid –alcohol 
solutions after staining with aryl methane dyes such as carbol fuchsin. This 
feature is of utmost practical importance in identifying the tubercle bacillus, 
particularly in pathological specimens (Barrera 2007). 
In spite of being a hallmark, the wall permeability to alkaline dyes and the 
mechanisms preventing their removal by acids are still not totally 
understood in molecular terms. Most of the current knowledge on this 
phenomenon was disclosed in pioneer expermints. The beading observed 
inside the cells was interpreted as accumulation of free dye rather than 
staining of particular structures, which lead to the early hypothesis that 
alkaline stains are retained in the cytoplasm (Yegian and Vanderlinde 1947).  
Later evidence was provided sustaining the role of lipids in trapping the 
dyes. Indeed, there is parallelism between the increasing degree of acid 
fastness displayed by microorganisms in the genera corynebacterium,  
nocardia , and mycobacterium , and the increasing length  of mycolic acid 
chains in their walls, this correspondence suggests that the chemical binding 
of the dye to these molecules might be a determinant for acid  fastness  
(Barrera 2007). 
1.6 Nutritional and environmental requirements for growth 
The tubercle bacillus is prototrophic (i.e. it can build all its components from 
basic carbon and nitrogen sources) and heterotrophic (i.e. it uses already 
synthesized organic compounds as a source of carbon and energy) 
(Palomino et al 2007). The microorganism macromolecular structure and 
physiological (metabolic) capabilities result in high adaptation to the specific 
environment. In turn, the nutritional quality of the environment determines 
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the bacillus life style and limitations, either in the natural habitat or in 
culture media, as do various physical conditions such as oxygen availability, 
temperature, pH and salinity (Palomino et al 2007). 
As the environment changes, the bacillus is able to bring into play different 
physiological pathways in order to survive even in harsh conditions. This is 
a highly resourceful strategy, not only for pathogenicity but also for species 
persistence (Palomino et al 2007). 
It has been shown that, during the course of infection in mice, M. 
tuberculosis metabolism may shift from an aerobic, carbohydrate-
metabolizing mode to one that is more microaerophilic and utilizes lipids 
(Segal 1956). These demonstrations, which were reported a long time ago, 
were supported in recent times by the complete sequencing of the M. 
tuberculosis genome in which an unusually high number of genes putatively 
involved in fatty acid metabolism were identified. This phenomenon may be 
related to the ability of the pathogen to grow or persist in host tissues where 
fatty acids may be the major carbon source (Neyrolles 2006). 
In vitro, the members of the M. tuberculosis complex are not fastidious 
unless damaged by some noxious agents (Wayne 1982). In fact, the medium 
used by Koch to cultivate M. tuberculosis was simply sterile coagulated 
blood serum (Wayne 1982). The tubercle bacilli can also grow in salt 
solutions using glycerol as a carbon source, ammonium ions and asparagine 
as nitrogen sources, and micronutrients. M. tuberculosis is able to 
metabolize glycerol into pyruvate, whereas M. bovis is not Indeed, the 
genome sequence analysis confirmed that all the genes required for the 
formation of pyruvate are non-functional in M. bovis. Being defective in this 
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metabolic process, M. bovis grows much better in the presence of a pyruvate 
salt as a source of carbon. Albumin, which is normally provided by adding 
eggs or bovine serum albumin to the culture media, promotes the growth of 
these microorganisms. Other subsidiary media components may be used, 
such as Tween 80, a detergent that disperses the bacilli in liquid media. It 
was postulated that bovine serum albumin may bind the excess of oleate that 
can be released from the detergent up to toxic amounts . Biotin and catalase 
have been incorporated to the Middle brook series media to stimulate the 
revival of damaged bacilli in clinical specimens (Wayne1982). 
Trace elements found by the microorganism in the water, inorganic ions, 
small molecules, and macromolecules have either a structural or a functional 
role in the cell. Magnesium and iron are essential for life. A deficiency in 
these elements frequently reduces the virulence of bacterial pathogens, 
including the tubercle bacillus (De Voss 2000). 
As iron is usually in the form of insoluble ferric salts in the environment, 
special iron systems are required to incorporate this element into the cell. 
Exochelinsand mycobactins are the major siderophores used by 
mycobacteria to perform this function. The former are hydrophilic peptides 
secreted into the environment for iron gathering. The latter are hydrophobic 
compounds located within the cell wall to introduce the iron into the 
cytoplasm (De Voss 2000). The mbt operon is putatively involved in the 
synthase activities required to produce the mycobactin core (De Voss 2000). 
The incorporation of mycobactin into culture media can promote the growth 
of ailing M. tuberculosis isolates (Palomino et al 2007). 
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The tubercle bacillus requires oxygen as a final electron acceptor in aerobic 
respiration. Molecular oxygen is reduced to water in the last step of the 
electron transport system (Palomino et al 2007). In nature, the bacillus 
grows most successfully in tissues with high oxygen partial tension, such as 
the lungs, particularly the well-aerated upper lobes (Palomino et al 2007). 
Carbon dioxide is essential and may be taken from the atmosphere and also 
from carbonates or bicarbonates. In the laboratory, an atmosphere of 5 to 10 
% carbon dioxide favors culture growth, at least during the early stage of 
incubation. On the other hand, M. bovis is microaerophilic, i.e. it grows 
preferentially at a reduced oxygen tension (Palomino et al 2007). 
M. tuberculosis is mesophile and neutrophile as its multiplication is 
restricted to conditions offered by warm-blooded animals: about 37ºC and a 
neutral pH. The temperature and hydrogen ion concentration ranges, in 
which the bacillus is able to multiply, are relatively narrow (Palomino et al 
2007). High saline concentration such as that found in media containing 5 % 
sodium chloride inhibits the growth of the microorganism (Palomino et al 
2007). 
1.7 Generation time 
 It is extremely slow compared to that of most cultivable bacteria, which 
duplicate at regular intervals ranging from about 15 minutes to one hour.  
 Recently, the low multiplication rate of tubercle bacillus was nicely exposed 
by(Chauhan et al 2006). They demonstrated the small proportion of cells 
initiating the septation process prior to division among tubercle bacilli 
growing either in broth or inside macrophage (Chauhan et al 2006). 
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The slow growth rate might be partially determined by the cell wall 
impermeability that limits nutrient uptake. However, only a minimal 
stimulus to bacterial multiplication is achieved when the permeability is 
increased through treatment with some compounds that interact with the cell 
envelope. Harshey and Ramakrishnan (1977) identified that ribonucleic acid 
(RNA) synthesis was identified to a major factor associated with long 
generation time of the tubercle bacillus. They demonstrated that both the 
ratio of RNA and DNA and RNA chain elongation rate are ten –fold lower 
in M.tuberculosis compared to E.coli (Harshey and Ramakrishnan1977). 
Another unusual feature is existence of unique operon commanding RNA 
synthesis. Furthermore, when the tubercle bacillus switches from the 
stationary to the active multiplying phase, its total RNA content increases 
only two fold. 
Consequently, the protein synthesis must be retarded (Verma et al1999). The 
influence of nutrient availability on the ribosome synthesis rate, which is a 
proxy of metabolic activity, remains controversial (Hampshire et al 2004). 
The low multiplication rate explains the typically sub-acute to chronic 
evaluation of the disease and the long time required to attain visible growth 
in vitro. Numerous experiments using different nutrients and culture 
conditions have demonstrated that some factors may abrogate a lag in 
adaptation of the bacilli in culture media but, once growth is initiated, the 
replication cycle will still take no less than 12 hours. This limitation in 
accelerating the tubercle bacillus growth could not be overcome.  
Instead, the main achievements for diagnosis have been made through the 
use of tools that enable the detection of a minimal quantity of bacilli in the 
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media. First, transparent agar medium allowing the detection of tiny colonies 
were introduced; more recently, the addition of biosensor has been adopted 
to detect redox changes produced by the bacilli metabolism (Barrera 2007).  
1.8 Susceptibility to Physical and Chemical Agents  
Mycobacteria are able to survive for weeks to months on inanimate objective 
if protected from sunlight. Members of the M. tuberculosis complex, for 
instance, survive for several months on surface or in soil or cow dung, from 
which other animals may be infected. Mycobacteria are easily killed by heat 
(>65°C for at least 30 min) and by UV (sun) light but not by freezing of 
desiccation. They are more resistant to acids, alkalies, and some chemical 
disinfectant than most non spore forming bacteria. Quaternary ammonium 
compounds, hexachlorophene, and chlorhexidine are bacteriostatic at best. 
The concentration of malachite green in egg-based media (e.g. LJ medium) 
was selected to maximize the growth of mycobacteria while inhibiting that 
of other microorganism. Other commonly used sterilants, such as ethylene 
oxide and formaldehyde vapor, as well as disinfectants such as chlorine 
compounds, 70% ethanol, 2% alkaline glutaraldehyde, peracetic acid, and 
stabilized hydrogen peroxide, is effective in killing of M. tuberculosis. 
However, agent that is inactivated in the presence of inorganic matter (e.g. 
alcohol) cannot be relied upon to disinfect sputum and other protein-
containing materials. With iodophors, the bactericidal effect depends on the 
content of available iodine as well as on the presence of organic matter 
(Murray et al 2007).   
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1.9 Epidemiology  
Tuberculosis is the world’s leading cause of death from a single infectious 
disease, with two million deaths (without HIV infection) in 1990. This is the 
result of inadequate programmes for disease control, multiple drug 
resistance, co-infection with HIV and rapid rise in the world’s population  of 
young adults – the age group with the highest mortality from tuberculosis 
(Kumar and Clark  2001). 
TB is contagious and spreads through the air; if not treated, each person with 
active TB infects an average 10 to 15 people every year (WHO 2008).  1 in 
10 people infected with TB bacilli will become sick with active TB in their 
lifetime; people with HIV are at much greater risk. More than 2 billion 
people, equal to one-third of the world’s population, are infected with TB 
bacilli, the microbes that cause TB (WHO 2008). 
TB is a disease of poverty; affecting mostly young adults in their most 
productive years. The vast majority of TB deaths are in the developing 
world, with more than half of all deaths occurring in Asia, 1.7 million people 
died from TB in 2006 including 231,000 people with HIV. This is equal to 
4,500 deaths a day. There were 9.2 million new TB cases in 2006, including 
709,000 cases among people living with HIV. TB annual incidence rates 
have peaked globally in 2003-2004. However they are falling very slowly in 
all WHO regions, and stagnating in Europe. The total number of deaths and 
cases is still rising due to population growth, Progress in controlling TB 
slowed in 2006 with only a 3% increase in rates of cases detected, compared 
to an average 6% increase per year between 2001 and 2005 (WHO 2008). 
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1.9.1 Epidemiology of TB among HIV patients  
Globally, nearly 4 out of 10 TB cases are still not being properly detected 
and treated. TB is a leading killer of people with HIV. People who are HIV-
positive and infected with TB are up to 50 times more likely to develop 
active TB in their lifetime than people who are HIV-negative Africa 
accounted for 85% of estimated global HIV positive TB cases in 2006. 
Though South Africa represents 0.7% of the world's population, it has 28% 
of the global number of HIV-positive TB cases (WHO 2008) 
1.9.2 Epidemiology of Multidrug-resistant TB : 
Multidrug-resistant TB (MDR-TB) is a form of TB that is difficult and 
expensive to treat and fails to respond to standard first line drugs. 
Extensively drug-resistant TB (XDR-TB) occurs when resistance to second-
line drugs develops on top of MDR-TB. XDR-TB is virtually untreatable 5% 
of all TB cases have MDR-TB, based on data from more than 100 countries 
collected during the last decade every year; an estimated 490,000 new 
MDR-TB cases occur causing more than 130,000 deaths. The former Soviet 
Union countries and China account for the highest rates. There are an 
estimated 40,000 new XDR-TB cases annually (WHO 2008). 
1.10 Physiology  
In tuberculosis, the tubercle bacilli cause a peculiar tissue reaction in the 
lungs, including invasion of the infected region by macrophages and walling 
off of the lesion by fibrous tissue to form the so-called tubercle. This walling 
– off process helps limit further transmission of the tubercle bacilli in the 
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lungs and therefore is part of the protective process against the infection 
(Guyton 1992).  
However, in approximately 3% of all persons who contract tuberculosis, if 
untreated, the walling – off process fails, and tubercle bacilli spread 
throughout the lungs, often causing extreme destruction of lung tissue with 
formation of large abscess cavities (Guyton 1992). Thus, tuberculosis in its 
late stages causes many areas of fibrosis throughout the lungs and reduces 
the total amount of functional lung tissue. These effects cause increased 
‘’work’’ on the part of the respiratory muscles to cause pulmonary 
ventilation and reduced vital capacity and breathing capacity, and reduced 
total respiratory membrane surface area and increased thickness of the 
respiratory membrane, these causing progressively diminished pulmonary 
diffusing capacity (Guyton 1992).  
1.11 Virulence Mechanism  
The basis for M. tuberculosis virulence is largely unknown. It produces no 
exotoxins, and both the intact cell and cellular components are remarkably 
innocuous to humans and experimental animals not previously sensitized to 
tuberculin. Cell wall components such as LAM have been implicated in 
binding to alveolar macrophages, utilizing surface fibronectin, mannose, or 
complement receptors (CR1, CR3). Once inside, multiple factors contribute 
to survival and continued multiplication. A number of genes have been 
identified that are linked to virulence by enhancing survival in the 
macrophage or by influencing the physical and chemical conditions (low pH, 
high lactic acid, high CO2) present in developing lesions, but their function 
remains unknown. Mycolic acids, sulfolipids, LAM, and proteins have been 
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shown to disrupt phagosome–lysosome interactions and interfer with 
oxidative killing. LAM has also been shown to modulate cytokine 
production and down regulate other aspects of T-cell function including 
antigen presentation (Ryan and Ray 2004).   
1.12 Pathogenesis  
1.12.1Size of Infectious Particle 
When inhaled, only fine particles or “droplet nuclei” containing 1–3 tubercle 
bacilli are capable of starting the infection, because they remain suspended 
in the air stream that enters the alveolar spaces. The heavier droplet nuclei 
containing more bacilli and/or bits of caseous material impinge upon the 
mucosal surfaces of both the nasopharynx and the bronchial tree. The 
bacillary particles are moved up the bronchial tree by cilia and eventually 
swallowed. The mucosal surfaces of the respiratory and gastrointestinal 
systems are not easily infected by tubercle bacilli since very large numbers 
of bacilli are required to do so (Manabe 2006). 
1.12.2 Clinical features 
Mycobacterium tuberculosis may affect every organ of the body: it mimics 
both inflammatory and malignant diseases. Pulmonary tuberculosis may 
present with a chronic cough, haemoptysis, fever and weight loss or as 
recurrent bacterial pneumonia (Gillespie and Bamford 2003). Untreated, the 
infection follows a chronic, deteriorating course. Tuberculous meningitis 
presents with fever and slowly deteriorating level of consciousness. Kidney 
infection may lead to signs of local infection, fever and weight loss, 
complicated by ureteric fibrosis and hydronephrosis. The lumbosacral spine 
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is common site of bone infection: progression may cause vertebral collapse 
and nerve compression. Additionally, pus may spread under the psoas sheath 
to appear as a groin swelling ( psoas abscess ). Infection of large joints may 
lead to a destructive arthritis. In abdominal infection, mesenteric 
lymphoadenopathy and chronic peritonitis may present as fever, weight loss, 
ascites and intestinal malabsorption. Disseminated infection ( miliary disease 
) can occur without evidence of active lung infection (Gillespie and Bamford 
2003). 
1.12.3 Primary tuberculosis  
The first infection with M. tuberculosis is known as primary tuberculosis. It 
is usually subpleural, often in the mid to upper zones. Within an hour of 
reaching the lung, tubercle bacilli reach the draining lymph nodes at the 
hilum of the lung and a few escapes into the bloodstream (Kuamr and Clark 
2001). 
The initial reaction comprises exudation and infiltration with neutrophil 
granulocytes. These are rapidly replaced by macrophages that ingest the 
bacilli. These interact with T lymphocytes, with the development of cellular 
immunity that can be demonstrated 3 – 8 weeks after the initial infection by 
a positive reaction in the skin to an intradermal injection of protein from 
tubercle bacilli ( tuberculin ) ( Kuamr and Clark 2001 ). 
At this stage, the classical pathology of tuberculosis can be seen. 
Granulomatous lesions consist of a central area of necrotic material of a 
cheesy nature, called caseation, surrounded by epithelioid cells and 
Langhans’ giant cells with multiple nuclei, both cells being derived from the 
macrophage (Kuamr and Clark 2001). Lymphocytes are present and there is 
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a varying degree of fibrosis. Subsequently the caseated areas heal 
completely and many become calcified. It is known that at least 20% of 
these calcified primary lesions contain tubercle bacilli, initially lying 
dormant but capable of being activated by depression of the host defense 
system (Kuamr and Clark 2001). Reactivation leads to typical post – primary 
pulmonary tuberculosis with cavitations, usually in the apex or upper zone 
of the lung.  ‘Post – primary tuberculosis’ refers to all forms of tuberculosis 
that occur after the first few weeks of the primary infection when immunity 
to the mycobacterium has developed (Kuamr and Clark 2001). 
1.12.4 Adult Post-Primary Pulmonary Tuberculosis 
Reactivation usually occurs in body areas of relatively high oxygen tension 
and low lymphatic drainage, most often in the apex of the lung. The lesions 
show spreading, coalescing tubercles with numerous tubercle bacilli, and 
large areas of caseous necrosis. Necrosis often involves the wall of a small 
bronchus from which the necrotic material is discharged, resulting in a 
pulmonary cavity and bronchial spread. Frequently, small blood vessels are 
also eroded. The chronic fever and weight loss may be mediated in part by 
macrophage-derived tumor necrosis factor (Ryan and Ray 2004). 
1.12.5 Miliary tuberculosis 
This disease is the result of acute dissemination of tubercle bacilli via the 
blood stream. It can be a difficult diagnosis to make especially in older 
people, where it is particularly covered (Kuamr and Clark 2001). 
Disseminated tuberculosis is universally fatal without treatment. It may 
present in entirely on specific manner with the gradual onset of vague ill-
health, loss of weight and then fever (Kuamr and Clark 2001). Occasionally 
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the disease presents as tuberculous meningitis. Usually there are no 
abnormal physical signs in the early stages; also eventually the spleen and 
liver become enlarged. (Kuamr and Clark 2001). 
The chest x-ray may be entirely normal in miliary tuberculosis as tubercles 
are not visible until uniform miliary shadows 1 – 2 mm in diameter are seen 
throughout the lung; they have a hard outline. The lesion can increase in size 
up to 5 – 10 mm. Sarcoidosis and Staphylococcal or Mycoplasma 
pneumonia can mimic the chest x-ray appearance of miliary tuberculosis. CT 
scanning may reveal lung parynchymal abnormalities at an earlier stage. The 
Mantoux test is positive but is occasionally in people with very severe 
disease. Trans-bronchial biopsies are frequently positive before any 
abnormality is visible on the chest x-ray (Kuamr and Clark 2001). 
Biopsy and culture of liver and bone marrow may be necessary in patients 
presenting with pyrexia of unknown origin (PUO). A trial of antituberculous 
therapy can be used in individuals with a PUO. The fever should continue 
within two weeks of starting chemotherapy if it is due to tuberculosis. This 
approach is used in susceptible individuals when a diagnosis cannot be 
confirmed (Kuamr and Clark 2001). 
1.13 Immunity  
Elimination of M. tuberculosis infection mainly depends on the success of 
the interaction between infected macrophages and T lymphocytes. Primary 
as well as acquired immunodeficiency, especially human immunodeficiency 
virus infection, has dramatically shown the importance of cellular immunity 
in tuberculosis. CD4+ T cells exert their protective effect by the production 
of cytokines, primarily gamma interferon (IFN- ), after stimulation with 
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mycobacterial antigens. Other T-cell subsets, like CD8+ T cells, are likely to 
contribute as well, by secreting cytokines and lysing infected cells. The T-
cell response is mostly antigen specific, and attention has focused on the 
identification of immunodominant antigens which might be used for the 
development of effective vaccines. The acquired T-cell response develops in 
the context of the major histocompatibility complex (MHC), and 
polymorphism of MHC may contribute to differences in disease 
susceptibility or outcome (Crevel et al 2002).  
Functional diversity of T lymphocytes may also be relevant. In 1986, it was 
reported that murine helper T (Th) lymphocytes could be divided into two 
subsets: Th1 clones were characterized by the production of IFN- , and Th2 
clones were characterized by the production of interleukin 4 (IL-4). Both 
subsets develop from naive T cells, whose differentiation is influenced by 
the environment: IL-12, produced by activated macrophages and dendritic 
cells, is the principal Th1-inducing cytokine, while IL-4 promotes induction 
of Th2 cells. More cytokines and different cellular subsets have been 
included in this Th1-Th2 concept, which is thought to be relevant in many 
disease entities. In mycobacterial infection, Th1-type cytokines seem 
essential for protective immunity. Indeed, IFN-  gene knockout (KO) mice 
are highly susceptible to M. tuberculosis, and individuals lacking receptors 
for IFN-  suffer from recurrent, sometimes lethal mycobacterial infections. 
Th2-type cytokines inhibit the in vitro production of IFN- , as well as the 
activation of macrophages, and may therefore weaken host defense               
(Crevel et al 2002).  
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1.14. Diagnosis of Tuberculosis : 
Pulmonary TB can be diagnosed by its symptoms, chest radiography, 
sputum smear microscopy and by cultivation of M. tuberculosis, which is 
considered as the gold standard method. Recent advances in molecular 
biology and molecular epidemiology may be used for T.B diagnosis 
(Palomino 2005). 
Active tuberculosis (TB) is diagnosed by detecting M. tuberculosis complex 
bacilli in specimens from the respiratory tract (pulmonary TB) or in 
specimens from other bodily sites (extra pulmonary TB). Although many 
new (molecular) diagnostic methods have been developed, acid fast bacilli 
(AFB) smear microscopy and culture on Lowenstein-Jensen medium are still 
the “gold standards” for the diagnosis of active TB and, especially in low-
resource countries, the only methods available for confirming TB in patients 
with a clinical presumption of active disease. AFB smear microscopy is 
rapid and inexpensive and thus is a very useful method to identify highly 
contagious patients. Culture is used to detect cases with low mycobacterial 
loads and is also requested in cases at risk of drug-resistant TB for drug 
susceptibility testing, or in cases where disease due to another member of the 
Mycobacterium genus is suspected. AFB smear microscopy and culture can 
also be used to monitor the effectiveness of treatment and can help to 
determine when a patient is less likely to be infectious (Kent and Kubica 
1985 , Master 1992). 
1.14.1. Specimens  
The successful isolation of the pathogen requires the best specimen be 
properly collected, transported and carefully processed. Many different types 
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of clinical specimens may be obtained for the microbiological diagnosis. If 
pulmonary TB is suspected, specimens originating from the respiratory tract 
should be collected, i.e. sputum, bronchoalveolar. lavage or a lung biopsy. 
For the diagnosis of pulmonary TB, three first-morning sputum specimens 
(not saliva) obtained after a deep, productive cough on non-consecutive days 
are usually recommended. In patients who cannot produce it spontaneously, 
the sputum can be induced by inhalation of hypertonic saline solution 
(Dorronsoro et al 2000 , Finch and Beaty 1997). 
Specimens to be collected for the diagnosis of extra pulmonary disease 
depend on the site of the disease. The most common specimens received in 
the laboratory are biopsies, aspirates, pus, urine, and normally sterile body 
fluids, including cerebrospinal fluid, synovial, pleural, pericardial, and 
peritoneal liquid. Stool can be collected when intestinal TB is suspected and 
also in the case of suspected Mycobacterium avium infection in AIDS 
patients. Whole blood and bone marrow specimens are collected only if 
disseminated TB is suspected, mainly in patients with an underlying severe 
immunosuppressive condition such as AIDS. Bone biopsies are the 
specimen of choice when skeletal TB is suspected. In general, AFB smear 
microscopy body fluid is rarely positive and the whole sediment from 
concentrated specimens should rather be cultured. In tuberculous pleural 
effusions, the diagnostic value of the pleural biopsy is much higher than that 
of the fluid and, therefore, is the specimen of choice for the diagnosis 
(Escudero et al 1990 ,Valdes et al 1998).  
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1.14.2 Transportation of Specimen 
Specimens should be transported rapidly to the laboratory to avoid 
overgrowth by other microorganisms. Specimens should be stored for not 
more than five days at 4°C until transported or presented for bacteriological 
processing. The cetylpyridinium chloride (CPC) method is widely used for 
the transport of sputum specimens (Smithwick et al 1975). CPC eliminates 
the associated flora in sputum specimens and treated specimens should not 
be submitted to further decontamination prior to cultivation. The detection of 
AFB with Ziehl- Neelsen staining can be significantly reduced in specimens 
preserved by this method (Selvakumar et al 2006). 
Also, CPC inhibits mycobacterial growth, especially when inoculated in 
culture media including Middle brook 7H9 and 7H10, which have an 
insufficient neutralizing activity for this quaternary ammonium compound. 
Therefore, specimens treated with CPC should be preferentially inoculated 
in egg-based media (Smithwick et al 1975).  
In a comparative study, sodium carbonate was found to be a better 
preservative of sputum specimens for AFB smear microscopy as well as 
culture (Bobadilla et al 2003)  
1.14.3 AFB Smears Staining 
AFB smear microscopy plays an important role in the early diagnosis of 
mycobacterial infections because most mycobacteria grow slowly and 
culture results become available only after weeks of incubation. In addition, 
AFB smear microscopy is often the only available diagnostic method in 
developing countries. Smear staining is based on the high lipid content of the 
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cell wall of mycobacteria which makes them resistant to decolorization by 
acid-alcohol after the primary staining. Two methods, Ziehl-Neelsen and 
Kinyoun, utilize basic fuchsin in ethanol for primary staining. In both cases, 
AFB appear red after decolorization with acid alcohol. Ziehl-Neelsen is a 
hot acid-fast stain because the slide has to be heated during incubation with 
fuchsin. In contrast, Kinyoun staining is a cold acid-fast staining procedure 
and therefore does not require heating. Kinyoun's cold carbol fuchsin 
method is inferior to the Ziehl-Neelsen staining (Somoskovi et al 2001 , 
Deun et al 2005). Fluorescent auramine O staining also used but it’s 
expensive (Khaled and Enarson 2003). 
1.14.4Culture Technique of Sputum 
Acid-fast microscopy is easy and quick, but it does not confirm TB 
diagnosis because mycobacteria other than M. tuberculosis are also AFB in 
the smear microscopic examination. There are nonselective and selective 
mediums for culture of mycobacteria. Selective media contains antibiotics 
that inhibit growth of normal flora (Adjers et al 2003). In order to culture 
mycobacteria from clinical specimens, there are various kinds of solid and 
liquid media such as Lowenstein–Jensen, Kirchner, and the various 
Middlebrook formulations (7H9, 7H10, and 7H11) (Watterson and 
Drobniewski 2000). Specimens contaminated with normal bacterial flora 
such as sputum are inoculated in a selective medium containing 
antimicrobial agents; sterile body fluids are inoculated with solid and a broth 
media (McMurray 2000). 
The growth of solid culture media is 6 weeks or longer, whereas that of 
liquid culture media is usually 7–21 days. Therefore, specimens should be 
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cultured on solid and liquid media (Frieden et al 2003) at 35–37? C, with 5–
10% CO2. All cultures should be examined weekly for 8 weeks. The major 
advantages of solid cultures are that they make it possible to examine the 
morphology of colonies and visualize the pigmentation. These advantages 
are useful to differentiate the MTB from other non-tuberculous mycobacteria 
(NTM) (McMurray 2000). 
1.14.5 Decontamination and Homogenization  
Several methods have been used to minimize culture contamination when 
specimens from non-sterile body sites are processed. Most of these methods 
include the digestion of mucus or organic debris and treatment to eliminate 
micro-organisms from the normal flora. Both steps are done to maximize the 
probability of isolating mycobacteria in culture. No single decontamination 
method is applicable to all circumstances, laboratories and clinical 
specimens; therefore, a laboratory should use the best suited method that 
keeps the contamination rate between 3 % and 5 %. A contamination rate 
lower than 3 % may indicate that the procedure used is too harsh and may be 
killing the mycobacteria (Della 2004). 
1.14.6 Culture Media                                           
Different culture media are in use for the isolation of mycobacteria. The 
most common are based on egg and also contain high concentrations of 
malachite green to overcome contamination with other bacteria. In general, 
after preparing the sample, it is inoculated onto two Löwenstein- Jensen 
slants. In areas with a high incidence of bovine TB, a tube with Stonebrink 
medium should be added. M. bovis and other species of the M. tuberculosis 
complex (M. microti and M. africanum) are unable to use glycerol as a 
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carbon source due to the lack of a functioning pyruvate kinase. Thus, these 
organisms will often fail to grow on Löwenstein-Jensen medium, which 
contains glycerol as the only available carbon source. Stonebrink medium 
has the same composition as Löwenstein-Jensen, with the exception that 
glycerol is replaced by 0.5 % sodium pyruvate (Keating et al 2005).  
The Ogawa medium is another egg-based medium, which is comparable in 
its composition with Löwenstein-Jensen. It is more economic because it 
replaces asparagines by sodium glutamate, an amino acid more readily 
available and much cheaper. Modified Ogawa medium (pH 6.4) is the same 
egg-based Ogawa medium that has been acidified in such a way as to allow 
the direct inoculation of specimens decontaminated by the Kudoh method. 
This combination is very suitable for culturing sputum specimens in rural 
settings. Other culture media use,   Middle brook 7H10 and 7H11 are agar-
based media. Conventional culture media such as those based on egg and 
agar should be examined for growth twice a week for the first four weeks 
starting on day 3 to day 5 post inoculation,  and thereafter, once a week up to 
the eighth week. All specimens showing growth in culture should be 
confirmed as AFB by smear microscopy of the colonies and reported 
immediately as “culture positive for mycobacteria pending identification”. 
All cultures reported positive for mycobacteria should be identified to the 
level of species using either biochemical or molecular methods (Keating et 
al 2005). 
1.14.7 Identification 
The final species identification of M. tuberculosis is based on characteristics 
such as slow growth, colony morphology, and biochemical tests. Depending 
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on geographical and epidemiological circumstances, it may be necessary to 
differentiate species within the M. tuberculosis complex. An initial 
identification as M. tuberculosis is defined on AFB bacilli from slow 
growing, non-pigmented colonies that are niacin positive, are inhibited by p-
nitrobenzoic acid and display nitratase activity. Additional tests that confirm 
an isolate as M. tuberculosis are susceptibility to pyrazinamide, growth on 
thiophene carboxylic acid hydrazide, absence of catalase production at 68°C 
and absence of iron uptake (Valdes et al 1998). 
1.14.8 Molecular Characterization 
The advent of molecular methods, and their widespread use in population 
studies, introduced both new conceptual and new technological 
developments. The inference of phylogenies from molecular data goes back 
to the early ’90s with the development of software such as PHYLIP and 
PAUP (Felsenstein 1993 , Swofford 1998).  
In particular, the study of the M. tuberculosis complex phylogeny closely 
followed the development of increasing numbers of sophisticated 
genotyping methods. The way was opened by M. tuberculosis fingerprinting 
by restriction fragment length polymorphism based on insertion sequence 
IS6110 (IS6110 RFLP) ( Van embden et al 1993). However, the use of 
IS6110 RFLP in evolutionary genetics discovery was of limited value for 
many reasons: fast variation rate of this evolutionary marker ( De boer et 
al1999), complexity of forces driving its transposition and risk of genetic 
convergence (Fang et al 2001), nature of experimental data produced which 
requires sophisticated software for analysis, difficulty to build large sets of 
data (Salamon et al 1998). 
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1.14.9 Genotypic Methods 
Genotypic methods for drug resistance in TB look for the genetic 
determinants of resistance rather than the resistance phenotype, and involve 
two basic steps: nucleic acid amplification such as polymerase chain 
reaction (PCR), to amplify the sections of the M. tuberculosis genome 
known to be altered in resistant strains; and a second step of assessing the 
amplified products for specific mutations correlating with drug resistance 
(Palomino 2005).  
1.14.10 Polymerase Chain Reaction 
Diagnostic tests for tuberculosis are based on detection of Mycobacterium 
tuberculosis in clinical sample. Acid fast microscopy of sputum or other 
appropriate clinical specimens, followed by culture confirmation, remains 
the corner stone of the diagnosis of tuberculosis. These traditional 
bacteriological methods are slow and expensive. Furthermore, their 
sensitivity is quite low when clinical samples that contain small numbers of 
organisms are analyzed. Thus, the rapid direct tests that detect M. 
tuberculosis nucleic acid are very attractive for the laboratory diagnosis of 
tuberculosis. Eventually nucleic acid amplification assays will replace 
traditional methods and provide a more rapid and sensitive diagnosis 
(Persing et al 1993). 
1.15 Treatment 
The history of tuberculosis (TB) changed dramatically after the introduction 
of anti-mycobacterial agents. Drug treatment is fundamental for controlling 
TB, promoting the cure of the patients and breaking the chain of 
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transmission when the antituberculosis drug regimen is completely and 
correctly followed. Antituberculosis drug treatment started in 1944, when 
streptomycin (SM) and para-aminosalicylic acid (PAS) were discovered. In 
1950, the first trial was performed comparing the efficacy of SM and PAS 
both as monotherapy or combined. The study demonstrated that combined 
therapy was more effective and resulted in the first multidrug anti 
tuberculosis treatment that consisted of a long course of both drugs. In 1952, 
a third drug, isoniazid (INH), was added to the previous combination, 
greatly improving the efficacy of treatment, but which still had to be 
administered for 18-24 months. In 1960, ethambutol (EMB) substituted 
PAS, and the treatment course was reduced to 18 months. In the ’70s, with 
the introduction of rifampicin (RIF) into the combination, treatment was 
shortened to just nine months. Finally, in 1980, pyrazinamide (PZA) was 
introduced into the antituberculosis treatment, which could be reduced 
further to only six months. Two biological features explain why combined 
drug therapy is more effective at curing TB than monotherapy. One is that 
treatment of active TB with a single drug results in the selection of drug 
resistant bacilli and failure to eliminate the disease. The other is that 
different populations of tubercle bacilli -  each of them showing a distinct 
pattern of susceptibility for antituberculosis drugs -  may co-exist in a TB 
Patient (Shamputa et al 2006). 
The  two main objectives of Antituberculosis treatment are:  First, there is a 
need to rapidly kill those bacilli living extracellularly in lung cavities, which 
are metabolically active and are dividing continuously; this is required in 
order to attain the negativization of sputum and therefore to prevent further 
transmission of the disease. Second, it is necessary to achieve complete 
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sterilization and elimination of those bacilli replicating less actively in acidic 
and anoxic closed lesions, and to kill semi-dormant bacilli living 
intracellularly in other host tissues, otherwise these bacilli may persist and 
will be responsible for subsequent TB relapses. INH is the drug with the 
highest activity against rapidly dividing bacilli, whereas RIF and PZA have 
the greatest sterilizing activity against bacteria that are not dividing. These 
reasons, along with the prevention of drug resistance, support the use of a 
combination therapy for the treatment of TB (Onyebujoh et al 2005). 
Drugs for treating TB are usually classified as first- and second-line drugs. 
Traditionally, there are five first-line drugs: INH, RIF, PZA, EMB, and SM. 
Second-line drugs include the aminoglycosides kanamycin and amikacin, the 
polypeptide capreomycin, PAS, cycloserine, the thioamides, ethionamide 
and prothionamide and several fluoroquinolones such as moxifloxacin, 
levofloxacin and gatifloxacin. Some reports, however, include SM among 
the second-line drugs, since its use has declined in recent years, due to the 
high rates of resistance, and also, because other more effective drugs have 
been incorporated into the anti-tuberculosis treatment. Similarly, new drugs 
such as the rifamycin derivatives rifapentine and rifabutin can be considered 
among the first-line drugs, and in the near future, it is quite likely that some 
fluoroquinolones could be incorporated into the standard antituberculosis 
thus being considered as first-line drugs. The current short-course treatment 
for the complete elimination of active and dormant bacilli involves two 
phases: 
Initial phase: three or more drugs (usually isoniazid, rifampicin, 
pyrazinamide and ethambutol or streptomycin) are used for two months, and 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
39 
 
allow a rapid killing of actively dividing bacteria, resulting in the 
negativization of sputum (Crofton 1997). 
Continuation phase: fewer drugs (usually isoniazid and rifampicin) are 
used for 4 to 7 months, aimed at killing any remaining or dormant bacilli and 
preventing recurrence (Crofton 1997). 
1.2.15.1 Treatment Regimens 
The World Health Organization (WHO) has established four TB diagnostic 
categories, assuming from a public health perspective that the highest 
priority of national TB programs is to identify and cure those patients with 
sputum smear-positive pulmonary TB, i.e. infectious TB patients (WHO 
2003).  
Category I comprises those patients with a high priority for treatment who 
are new smear-positive patients, new smear-negative pulmonary TB patients 
with extensive parenchymal involvement, patients with concomitant 
HIV/acquired immunodeficiency syndrome (AIDS) disease or severe forms 
of extrapulmonary TB. Patients with a lower priority for treatment are 
classified as follows: Category II (relapse, treatment failure or default), 
Category III (new smear-negative pulmonary TB other than in Category I 
and less severe forms of extrapulmonary TB) and Category IV (chronic 
sputum-positive TB after re-treatment and proven or suspected MDR-TB) 
(WHO 2003). 
In general, the duration of the continuation phase must be estimated once the 
first two months of treatment (initial phase) have been completed. If the 
patient had cavitations on initial chest radiography and cultures are still 
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positive after two months of treatment, the continuation phase should be 
extended to 31 weeks (seven months). When drug resistance develops, 
patients should be treated with a new combination containing at least three 
drugs that they had never received before. In these conditions, the treatment 
is longer, more toxic, more expensive and less effective than regimens 
containing first-line drugs, and should be directly observed. In children, drug 
regimens similar to those described above for adults can be given, although 
EMB is not recommended because of its ocular toxicity. Rifapentine has not 
been approved for pediatric use. In case of pregnancy, similar drug regimens 
can be prescribed, although SM and other second-line aminoglycosides must 
not be given because they are ototoxic for the fetus (WHO 2003). 
1.15.2 Chemotherapy   
1.15.2.1 Isoniazid  
INH is a pro-drug that requires processing by the bacterial catalase-
peroxidase to become active. Once activated, it inhibits the biosynthesis of 
mycolic acids, which are essential components of the mycobacterial cell 
wall. This drug is bactericidal against metabolically active bacilli and 
bacteriostatic against resting bacilli. INH is active against M. tuberculosis, 
M. bovis and M. kansasii. Susceptible M. tuberculosis strains show minimal 
inhibitory concentrations (MIC) between 0.02 and 0.2 mg/L (WHO 2003).  
1.15.2.2 Rifampicin 
A semi synthetic derivative of rifampicin (RIF),complex macrocyclic 
antibiotic that inhibits ribonucleic acid synthesis in a broad range of 
microbial pathogens. It has bactericidal action and a potent sterilizing effect 
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against tubercle bacilli in both cellular and extra-cellular locations. 
Rifampicin is lipid-soluble. Since resistance readily develops, rifampicin 
must always be administered in combination with other effective anti-
mycobacterial agent (WHO 2003).               
1.15.2.3 Ethambutol 
Synthetic congener of 1,2-ethanediamine that is active against M. 
tuberculosis,  M. bovis   and some  non specific mycobacteria. It is used in 
combination with other antituberculosis drugs to prevent or delay the 
emergence of resistant strains. It is readily absorbed from the gastrointestinal 
tract. Plasma concentration peak is reached in 2-4 hour and decay with a 
half-life of 3-4 hour (WHO 2003).         
1.15.2.4 Streptomycin  
Streptomycin (SM) isolated by Waksman from a soil organism in 1943, 
streptomycin is now used in the form of streptomycin sulfate and is 
dispensed as a dry powder in vials. It is administered by intramuscular 
injection. The usual dose is 0.75-1g (12-18mg/kg), daily, two or three times 
a week, given in a single injection. In older patients and patients weighing 
less than 35kg, a dose of 0.5g is equally effective and less toxic(Frieden 
2004).    
1.16 Drug Resistance Mechanisms 
1.16.1 Natural Drug Resistance 
The natural drug resistance of M. tuberculosis is an important obstacle for 
the treatment and control of TB. This resistance has traditionally been 
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attributed to the unusual multi-layer cell envelope and active multidrug 
efflux pumps (Rossi et al 2006). Recent insights into mechanisms that 
neutralize the toxicity of antibiotics in the cytoplasm have revealed other 
systems that function in synergy with the permeability barrier and efflux 
systems to provide natural resistance. Drugs inhibiting these intrinsic 
systems would enable many antibiotics, which are already available but have 
not been used for TB, to gain a new potential use agains M. tuberculosis 
(Lomovskaya and Bostian 2006). 
1.16.2 Acquired Drug Resistance 
Knowledge of the molecular basis of drug resistance in M. tuberculosis 
increased with the sequencing of the genome and the development of 
molecular tools (Aínsa et al 2001). In other bacterial species, acquired drug 
resistance is mediated by plasmids or transposons, but in contrast, M. 
tuberculosis acquired drug resistance is caused by mutations in 
chromosomal genes. So far, no single pleiotropic mutation has been found in 
M. tuberculosis to cause a MDR phenotype. The MDR phenotype is caused 
by sequential accumulation of mutations in different genes involved in 
resistance to individual drugs, due to inappropriate treatment or poor 
adherence to treatment. However, it is important to observe that some 
resistant strains do not present these classic mutations, suggesting the 
possibility of the existence of other mechanisms such as efflux pumps and 
alterations in the permeability of the cell wall (Zhang and Telenti  2000).  
1.16.3 Multi-drug resistant Tuberculosis MDR-TB 
The incidence of tuberculosis has increased, there has been a corresponding 
rise in the incidence of drug- resistant strains of M. tuberculosis because of 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
43 
 
the prolonged infectivity which increases the risk of transmission (Doustdar 
et al 2008). 
 MTB develops resistance to a drug by random genetic mutation. Resistance 
to individual drugs occurs infrequently and the rate of mutation has been 
estimated to be approximately one in 106–107 organisms. Because the 
mutations are unlinked, the probability of a single MTB organism 
developing resistance to two drugs is the product of the drug-specific 
mutation rate. Since the number of bacilli in a patient with active TB rarely 
exceeds 109/ml, two drugs given simultaneously make the likelihood of 
spontaneous drug resistance unlikely. Preventive therapy with a single drug 
is effective because the numbers of organisms in individuals with TB 
infection, in contrast to those with TB, are small (Schlossberg 2006). 
1.17Control of Infection  
The most effective way to interrupt the transmission of M. tuberculosis is to    
identify and treat the individuals who have active tuberculosis. However M. 
tuberculosis continues to be transmitted to other individuals largely because 
most of transmission occurs before diagnosis and initiation of therapy 
(Daley 2005). 
1.17.1 Direct Observation-Short Course Strategy (DOTS) 
 The internationally recommended control strategy for TB control has long 
been proven to cure patients, save live and reduce the transmission of 
disease (Kumaressan et al 2004). The DOTS strategy comprises five key 
elements: I-fully supervised treatment with standardized short-course 
regiment; II- case detection, with special attention to the use of sputum 
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microscopy; III- reliable drug provision; IV- effective monitoring of TB 
control programs; and V-government commitment to TB control (Bastian et 
al 2000). Direct observed treatment –short course strategy, means that  
Laboratories are physically separated from other laboratory area. The 
objective is to reduce the infection risk, not only to tuberculosis supervisor 
watches the patients swallowing the tablets, but ensures that a TB patient 
takes the right drugs, in the right doses, at the right intervals .in many 
countries, supervisors have observed patients treatment in in-patients setting 
in hospitals or in sanatoria. Supervisors have also directly observed 
treatment in outpatient's settings.  The Supervisors may be a health worker 
or a trained supervised community member (Mahar et al 1997).The case 
detection rate by DOTS programs increased almost linearly from 
11%globally in 1995 to 28%in 2003.  (Dye et al 2005).       
 1.17.2 Vaccination 
Neither dead vaccines of tubercle bacilli nor tuberculin will stimulate 
immunity against tuberculosis. Immunity can, however, be produced by the 
use of living vaccine, consisting of strain of bovine bacilli, Bacille Calmette-
Guerin (BCG) attenuated by prolong culture on a bile-containing medium. 
The BCG strains are not completely virulent. It will grow to a limited extent 
in tissues; in fact its immunizing effectiveness appears to depend on its 
being able to do so. It is, however attenuated to the extent that it does not 
normally initiate a progressive infection. The BCG vaccine strains currently 
employed differ considerably in their degree of attenuation. Consequently 
their immunizing potency must be kept continually under review; 
particularly to ensure that they do not become over-attenuated (Stewart 
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1974).When BCG vaccine was introduced in 1920s it was widely used in 
France where it was given orally. Although vaccination was popular, there 
were no statistically controlled trails and many considered the procedure 
unsafe. In 1930 BCG receive a setback (as does practically every new 
vaccine) with the Lubeck disaster in which 73infant (27percent) who had 
been fed with vaccine died. It was apparent that the children had accidentally 
been fed with a virulent strain of M .tuberculosis which had been kept in the 
same laboratory as the stock BCG strain. This disaster led to regulations 
controlling the production of BCG to ensure exclusion of all other strains 
(Dick1978). The current (BCG) vaccine, an attenuated strain of 
Mycobacterium bovis is a core component of the expanded program for 
immunization (EPI) (Fruth and Young 2004). The WHO recommends that 
infants should be immunized as soon after birth as possible with a single 
intradermal dose of BCG in all countries with a high risk of TB (Milstien 
1993).Although a consensus is developing that BCG protects children 
efficiently against the early manifestation of TB, estimates of protection 
against adults pulmonary TB range from 0-80% based on a large, well 
controlled field trails (Andersen and Doherty 2005).       
1.18 Bio-safety in Mycobacteriology Laboratory  
Mycobacterium tuberculosis is classified under Risk Group III. This group 
includes microorganisms that are particularly associated with infection by 
the airborne route. Precautions therefore involve measures to minimize the 
production and dispersal of aerosols and infected airborne particles and to 
prevent the laboratory workers from inhaling those that might be released, as 
well as measures intended to prevent infection by accidental ingestion and 
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inoculation. Mycobacterial culture should always be performed by 
containment technologists, but also by other individuals in the same 
building. (Kantor et al1998).  The single, most important piece of laboratory 
equipment needed in a tuberculosis culture laboratory is a well-maintained, 
properly functioning biological safety cabinet (BSC) (Kent and Kubica 
1985). These cabinets have been designed to provide a combination of staff, 
environmental or product protection when appropriate practices and 
procedures are followed. BSCs use high efficiency particulate air (HEPA) 
filters in their exhausting and/or air supply systems. HEPA filters remove 
particles equal to and greater than 0.3 µ m (which essentially includes all 
bacteria, spores and viruses) (Kantor et al 1998) 
Faced with the high cost of purchasing, maintaining and period testing of 
commercial and reliable BSCs, and the perceived hazards of laboratory-
acquired infections, several attempts have been made to design inexpensive 
homemade cabinets. (while it may be possible to construct a cabinet carcase 
from polywood, or other readily-available material that will approximate to 
the airodynamics and other specifications set out in the various national 
standards, no protection will be afforded to the operator unless the exhaust 
fan and system meets the specifications that have been determined by long 
and detailed investigations. It follows, also, that there must be an appropriate 
and reliable source of electrical power. Car batteries and solar generations 
are unlikely to be reliable. Any deviation from the standards that have been 
arrived at by many years of testing and experimentation by engineers, 
physicist and microbiologist will result in "safety cabinet" that are not safe 
and may be described as "danger boxes" (Collins and Johns 1998).        
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CHAPTER TWO 
Materials and Methods 
2.1 Study Design 
2.1.1. Type of the Study 
Prospective cross sectional study.  
2.1.2. Study Area 
Data of this study were collected from patients referred from different state 
to National Tuberculosis Reference Laboratory.  
2.1.3. Study Population  
Tuberculosis suspected patients. 
2.1.4. Data Collection 
Data were collected using a questionnaire with informed consent.  
2.1.5. Sample Size  
Patients referred to the National Tuberculosis Reference Lab. During  
The period from December 2010to March 2011 were included in this 
study  
(250 samples).the sample size was determined according to equation:                                    
n =  z ² .p .q  * d f 
      d² 
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z = the value in normal curve corresponding to level of confidence 95% = 
1.96  
p = probability prevalence in the community .since unknown 50% 0r .0.5 
take maximum  
q = (1-p) = 1-0.5= 0.5 
d = margin of error = .05 
df= design effect =1.5 
2.2 Collection of Specimens  
Verbal consent of participation in the current study was taken from 
participant and then epidemiological and clinical data were collected , every 
patient was provided with a clean, single use, disposable, screw capped 
plastic sputum container and instructed to produce the specimen by deep 
coughing in a well ventilated area. The specimen was transferred to the 
reference laboratory immediately and subjected to mycobacteriological 
processing methods.  
2.3 Identification of Mycobacterium (Conventional Methods) 
All procedures were carried under biological safety cabinet class II and 
chemical agents were prepared according to Kent and Kubica (1985). 
2.3.1 Direct Ziehl-Neelsen Stain  
Direct smears were made, fixed by heat, stained by ZN method and 
examined microscopically for acid fast bacilli as heated to steaming with 
filtered 1% carbol-fuchsin stain, let stand for 5mintues, riased with tap 
water. Then smears were flooded with alcoholic sulfuric acid (H2SO4), 
allowed for complete destaining, washed with tap water and drained. 
Flooded with methylene blue as counter stain for 1minute, washed with 
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water, and air dried, examined under oil immersion objective lens( appendix   
(I)  . 
 2.3.2 Culture of Mycobacteria  
2.3.2.1 Culture Media   
Lowenstein-Jensen medium (LJ) containing glycerol, or supplemented with 
pyruvate, were prepared in the laboratory ( appendix (II) and used according 
to Kent and Kubica,(1985). 
 2.3.2.2 Decontamination of Specimens  
Sputum was transferred to 50ml disposable plastic tube and an equal amount 
of 4% sodium hydroxide was added, vortexed and allowed to stand at room 
temperature for 20 minutes. The specimen was neutralized with 1NHCL 
containing 0.1% phenol red as an indicator. Then  inoculated onto three 
slopes of LJ medium, two containing glycerol and the other was 
supplemented with pyruvate. Finally an indirect smear was made and 
processed as mentioned previously. ( appendix (III) 
2.3.3 Isolation and Preservation Techniques 
2.3.3.1 Isolation 
All cultures were incubated in slope position for three days with loosen caps 
to evaporate the excess fluid then caps were closed tightly to prevent drying 
of media, placed in upright position and examined for contamination. Re-
examination was taken at first week to detect rapid growers and finally every 
week to detect slow growers up to the eighth week. The result was recorded  
as negative if no growth appeared, exact number of colonies was recorded as 
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(+) if the number of colonies is less than 20, (++) if the number of colonies 
is 20 to 100, (+++) if the number of colonies is100 to 200.   
2.3.3.2 Preservation 
Cultures were maintained through alternative subculture on LJ medium and 
were stored in 20% glycerol in distilled water at -200c until needed.   
2.3.4 Identification  
Isolates were firstly identified according to methods described by Kent and 
Kubica (1985). 
3.3.4.1 Primary Identification   
Isolates were firstly identified according to growth rate and colonial 
morphology.  
2.3.4.1.1 Growth Rate  
0.1ml of 10-4 and 10-2 bacillary suspension of each grower isolate was   
inoculated on LJ slopes, incubated at 370C and examined after 5 to 7days to 
identify the rapid growers by appearance of grossly visible colonies. 
2.3.4.1.2 Pigment Production  
Four slopes of LJ medium were inoculated with 10-4 bacillary                                                
suspension,  two of them were covered with aluminum foil, incubated at 
370C, growth was examined for pigmentation in unshielded slopes, and 
shields were removed and examined for pigmentation and exposed to light 
for 5 hours, then  the results were recorded. 
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2.3.4.2 Biochemical Test  
2.3.4.2.1 Catalase Test  
2.3.4.2.1.1 Heat Stable Catalase Test at (pH7/680C)  
Some bacteria lose catalase activity when suspended in a buffer with 
pH7and heated to 680C for 20 minutes. Included in this group are M. 
tuberculosis, M. bovis, M. gastri and M. haemophilum. This hot catalase test 
is valuable in identifying strains of M. tuberculosis which give weakly 
positive or negative niacin test. All slow-growing nonchromogens 
mycobacteria were subjected to this test. 
 In screw capped tube, several loopfuls of test culture were suspended in the 
buffer solution (as described in Appendix (IV). Tubes containing the 
emulsified cultures were placed in a previously heated water bath at 68°C 
for 20 minutes, time and temperature was critical. Tubes were removed from 
heat and allowed to cool to room temperature. 0.5 ml of the freshly prepared 
tween – peroxide mixture (as described in Appendix (V) was added to each 
and caps were placed loosely. Formation of bubbles was observed appearing 
on the surface of the liquid, the tubes should not be shaken because tween 80 
also may form bubbles when shaken resulting in false positive results. 
Negative tubes were held for 20 minutes before discarding. 
2.3.4.2.1.2 Semi-quantitative Catalase Test  
This test divides the mycobacteria into two groups, those producing less than 
45mm of bubbles and those producing more than 45mm of bubbles. 
Generally, M. kansassi, most scotochromogens, the nonphotochromogens 
saprophytes, and the rapid growers produce more than 45mm of bubbles in 
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this test. Among those that produce less than 45mmof bubbles are M. 
tuberculosis, M. marinum, M. avium complex, M. xenopi, M. gastri. 
Isolates were inoculated on LJ butt medium surface. Incubated at 370C for 
two weeks and 1ml of freshly prepared Tween-peroxide mixture was added 
and the height of column of bubbles above the medium surface was 
measured in millimeters.  
2.3.4.2.2 Nitrate Reduction Test  
The ability of some mycobacteria to reduce nitrate has proven valuable in 
differential identification of some mycobacteria that possess similar 
characteristics . observed   that  the   mycobacteria   differed              
quantitatively in their ability to reduce nitrate and this reaction is influenced 
by the age of the culture, temperature, enzyme inhibitors, and hydrogen ion 
concentration (Virtanen 1960). 
Isolates were emulsified in 2ml NaNO3(appendix (VI) substrate, incubated 
upright for two hours in a water bath at 370C, removed then added to the 
lame reagent (appendix (VII) and immediately examined for pink to red 
color. 
2.3.4.2.3 Para Nitro-benzoic Acid (PNB) 500mg/l Susceptibility Test 
0.1ml of 10-4 and 10-2 bacillary suspension were inoculated on two slopes of 
drug containing media and two slopes of drug -free media as a control, 
incubated at 370C for 4 weeks and the proportion of growth was calculated.  
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2.3.4.2.4 Thiophen-2-carboxylic Acid Hydrazide (TCH) 5ug/ml 
Susceptibility Test  
This test is valuable for distinguishing M. bovis from M. tuberculosis and 
other nonchromogenic slow growing mycobacteria. Only M. bovis is 
susceptible to low concentration of TCH, 1 to 5ug/ml. isoniazid-resistant 
strain of M. bovis may be resistant to TCH. For M. tuberculosis and other 
mycobacteria usually 0.1ml of 10-4 and 10-2 bacillary suspension were 
inoculated into two slopes of drug containing media and two slopes of drug-
free media as a control, incubated at 370C for 4 weeks and the proportion of 
growth was calculated. 
2.3.5 Drug Susceptibility Test (DST) (Proportion Method) 
An amount of 0.1ml of 10-4 bacillary suspension was inoculated on to two 
slopes of LJ as control number two, concentration of 10-2 bacillary 
suspension was also inoculated on to two slopes of LJ media as control 
number one, two slopes of LJ containing streptomycin 8.0ug/ml (SM), two 
slopes containing rifampcin 40.0ug/ml (RIF), two slopes containing 
isoniazid0.2ug/ml (INH), two slopes containing ethambutol 2.0ug/ml (EMB) 
were inoculated with a suspension of mycobacteria containing 10-2 bacilli.  
Cultures were examined after six weeks and were, interpreted as follow: if 
the percentage of colonies on drug containing media was less than 1% 
compared with control 2 the isolates were considered resistant if the 
proportion of growth was equal or greater than 1%. 
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2.3.5.1 Preparation of Stock Solution for Drugs  
2.3.5.1.1 Isoniazid  
20mg of isoniazid (potency: 1gto1g) was dissolved in 40ml distilled water to 
provide 500ug/ml solution 2ml of this solution was diluted to 50ml to give 
20ug/ml stock solution. 
2.3.5.1.2 Rifampicin  
80mg /potency of rifampicin (potency: 980ug/mg)  was dissolved in 5ml of 
absolute methanol and further diluted with 5 ml of 95% ethanol to provide 
8,000.0ug/ml stock solution (self-sterilizing ). 
2.3.5.1.3 Dihydro-Streptomycin Sulfate 
40mg of dihydro-streptomycin sulfate (potency: 667ug to 800ug/ml) was 
dissolved in 50ml sterile distilled water to provide 800ug/ml stock solution. 
2.3.5.1.4 Ethambutol 
20mg of ethambutol powder (potency: 1g to1g) was dissolved in sterile 
distilled water to provide 200ug/ml stock solution. 
2.3.6 Preparation of Drug Containing Media 
5ml of isoniazid stock solution was added to500ml of the LJ medium to 
provide 0.2ug/ml critical drug concentration, 2.5 ml of rifampicin stock 
solution was added to 500ml of L J medium to provide 40ug/ml critical drug 
concentration, 5ml of streptomycin   stock solution was added to 500ml of L 
J medium to provide 8ug/ml critical drug concentration and   5ml of 
ethambutol stock solution was added   to 500ml L J medium to provide 
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2ug/ml critical drug concentration. The media were inspissated at 850C for 
15 minutes, checked for contamination and stored in a refrigerator at (40C). 
the media was prepared to do the drug susceptibility test. 
2.3.6.1 PNB 
0.2g of PNB was dissolved in 15ml sterile distilled water and 2ml of 1N 
NaOH, neutralized with HCL 1N containing phenol red as indicator, end 
point was determined  and the volume was completed to 20ml and each 5 ml 
of drug was added to 100ml of L J medium, dispensed, and insipissated in 
slopes position. 
 2.3.6.2 TCH 
 25mg of TCH was dissolved in 20ml distilled water in water bath at  450C 
for 30 minutes and each 4 ml of drug  was  added to 1000 ml L J medium, 
dispensed  and insipissated in slopes  position.    
 2.3.7 Quality Control of Prepared Media   
 Every new batch of drug containing media was inoculated with 
Mycobacterium tuberculosis H37Rv sensitive strain to ensure the critical 
concentration of the drug contained in the media.  
2.3.8 Preparation of Bacillary Suspension   
The colonies were subculture at intervals of 1 to2 weeks, which  were placed 
into McCartney bottle containing 1ml of sterile distilled water and 6 to 8 
glass beads using an inoculating loop, homogenized on a vortex mixer   for 
up to 1 minute, the opacity of the suspension was adjusted by addition of 
sterile distilled water to match that of McFarland solution I 
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2.3.9 Preparation of McFarland Solution I 
 1%  solution of anhydrous barium chloride (BrCL2) and a 1 %( v/v) cold 
solution of pure sulfuric acid were prepared, 0.1 ml of  1%  BaCL2 was 
added to 9.9ml of 1% H2SO4  .to prepare McFarland tube. 
2.3.2 Polymerase Chain Reaction Method 
2.3.2.1 DNA Extraction by Boiling   
It was good, simple and cheap method. the colonies were Harvested (3-5 
loop full) in double distilled water 500ul in sterile eppendrof tube  , boiling 
in water bath 1000C for 10 minutes ,then centrifuged at 12000rpm for 5 
minutes , the supernatant was collected in sterile eppendorf tube  and used as 
template and stored in -200C until used.  
2.3.2.2 Primers of Insertion Sequence IS6110  
Amplification of insertion sequence IS6110 (123 bp) (Eisenach et al1990) 
was performed to identifythe the mycobacterium tuberculosis with a set of 
primers having the following sequence 
Forward: `5(CCTGCGAGCGTAGGCGTCGG)`3 
Reverse: 5`(CTCGTCCAGCGCCGCTTCGG)` 3 
3.3.2.3 Primers of Insertion Sequence of Rifampicin and Isoniazid genes 
A. Detection of rifampicin resistant gene rpoB by insertion of sequence 
rpoBTR8 and rpoTR9, which produced 158 bp (Tavakoli et al 2005) 
Upstream primer rpoTR8 (5' -TGCACGTCGCGGACCTCCA-3' ) 
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Downstream primer rpo TR9(5' -TCGCCGCGATCAAGGAGT-3' ), 
B. isoniazed resistant gene by insertion of sequence KatG and KasA, which 
produce 209bp and 1389bp. 
Upstream primer katG TB86(5' -GAAACAGCGGCGCTGATCGT- 3' ) 
Downstream primer katG TB87 (5' - GTTGTCCCATTTCGTCGGGG-3' ). 
Upstream primer Kas A51 (5' -ATTGAGTCGGAGAACCCCGA-3' ). 
Downstream primerkas A31 (5' -CCTTCCATATCGGTCCGACT-3' ). 
2.3.2.4 Preparation of PCR Mixture  
A master mix reagent was prepared for 25ul reactions according to 
(Eisenach et al1990), which contained: 
Buffer, 2.5ul; MgCL2 2.25 ul;for each dNTP ,0.625ul; Tag,0.125 ul ; 
D.W,17.25ul; Primer F, 0.5ul Primer R,0.5ul;DNA templet0.75ul.  
M. tuberculosis strain H37R was used as positive control. The negative 
control contained reaction mixture without template DNA. 
2.3.2.5 Polymerase Chine Reaction (PCR)    
The amplification was done using a thermal cycler from CONVERGYS® td 
peltier thermal cycle. A PCR program was conducted with an initial 5 
minutes denaturation step at 94°C for one cycle followed by a repeating 
cycle of denaturation  ( 30minutes at 94°C), annealing (45 minutes at 68°C) 
and extension ( 40 minutes at 72°C) for 40 cycles, followed by a 5 minutes 
final extension step at 72°C.  
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2.3.2.6 Preparation of Agarose  
1.5 gram of agarose (AppliChem) was dissolved by boiling in 100ml 1X 
TBE (AppliChem). Then, 5 µl of ethidium bromide were added before 
pouring the liquid agarose gel into the gel casting tray which was equipped 
with suitable comb and its open sides were closed and left to solidfy. After 
solidification, the comb was gently removed and the closure from the 
opened sides was removed.   
2.3.2.7 Visualization of PCR Product 
The gel casting tray was put into the electrophoresis tank, flooded with TBE 
buffer as just to cover the gel surface. 10 µl of PCR product from each 
sample were mixed with 2 µl of loading buffer and then the mixture was 
electrophoresed. 5 µl of DNA ladder (marker) were mixed with 3 µl loading 
buffer and were added to one well in each run. The gel electrophoresis 
apparatus was connected to a power pack (Serva Blue Power 500, 
Germany). The electrophoresis was carried at 50 V for 30-60 minutes. After 
electrophoresis period the gel tray was removed from the electrophoresis 
apparatus and the buffer was discarded. Then, the gel was visualized by UV 
transilluminator (SYNGENE, UK). 
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CHAPTER THREE 
Results 
3.1 Epidemiology Finding 
3.1.1 Gender 
Among the study population 250 patients, with pulmonary infection who 
were suspected to have tuberculosis, 171(68.4 %) were found to be males, 
while 79(31.6%) were females.(Figer 1) 
 
 
Figure 1. Distribution of patients with pulmonary infection according to  
Gender 
3.1.2 Age Group  
All  ages were found to be affected with tuberculosis, highest frequency was 
among age group 15 -45  years 187(74.8 %) , followed by age group  >46 
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years 58 ( 23.2%) while the lowest frequency was age group  0-14 years 5 ( 
2%). (Figer 2) 
 
(Finger 2).Correlation between MTC and age  
3.1.2 Sensitivity of Smears and Culture  
 Among enrolled patients (250) the results of direct ZN stain revealed  
91(36.4%) positive whereas 159 (63,6%) were negative at the same time, the 
result of culture showed 123(49.2 %) positive whereas 127 (50.8%) were 
negative. (Fig 3) 
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(Figure 3).The results of direct smears using ZN technique among 
suspected patients     
(Figer 4 ) 
 
(Figure 4). The results of culture technique among suspected patients. 
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3.1.3 Drug Susceptibility Test  
Drug susceptibility test was done to 123(49.2%) MTC isolates, 
45(18%)were MDR,45(18%)strains sensitive to first line drug,  18  (7.2%) 
strains were resistant to streptomycin,15 (6%) strains had triple resistance to 
isoniazid, ethambutol and streptomycin.(Figer 5) 
 
(Figure 5). The results of drug susceptibility test by using conventional 
method 
3.1.4 Multi-drug Resistant 
Among multi-drug resistant, the new cases were 22.2% and old cases were 
77.8 %. 
 Table 1. Multi-drug resistant (Old and New cases) 
 
Percentage Frequency MDR cases 
22.2 35 Old 
77.8 10 New 
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100 45 Total 
 
3.2 Bacteriological Findings 
A total of  250  patients  who attended tuberculosis reference lab during  the 
period from September to march 2010 and had clinical signs of pulmonary 
tuberculosis were examined for acid fast bacilli in their sputum using Ziel-
Neelsen (ZN) staining technique, other biochemical and molecular technique 
were performed. The results were as follows: 
3.2.1 Direct Ziehl-Neelsen Staining   
Direct staining were performed on all samples, that showed 91 (36.4%) were 
acid –fast bacilli positive and 159 (63.6%) were negative. 
4.2.2Isolate of MTB 
From the collected 250 sputum samples, 123 showed MTC-like colonies  but 
one sample revealed growth of MOTT ,and 127 showed no growth or 
contamination. The MTC-like colonies were subjected to varieties of tests. 
3.2.3 Growth Rate  
The growth time of the isolates ranged between (2-4) weeks were identified 
as slow growers and considered as member of MTC species. 
3.2.4 Indirect Ziehl-Neelsen Staining 
For confirmation, indirect ZN smears were performed for all samples that 
showed typical growth of MTC . 
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3.2.5 Cultural Characteristics  
Cultural properties of all isolates of Mycobacterium tuberculosis complex on 
Lowenstein Jensen medium at 37°C were almost the same and all colonies 
were found to be dry, rough and (buff) colored. 
3.2.6 Biochemical Tests  
Selected biochemical tests had been done, to identify the isolated   micro- 
organisms. The results were listed in table 2.  
Table 2.The result of selected biochemical test 
 
 
 
 
 
 
 
 
Key:- TCH: Thiophen-2Carboxylic Acid Hydrazide, PNB: paraNitro-
Benzoic Acid 
 
 
Biochemical  
Test    
Freq. Percentage 
Catalase in 680C 45 100 
Nitrate Reduction 45 100 
TCL 45 100 
PNB 45 100 
Total 45 100 
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3.3 Polymerase chain Reaction 
4.3.1 Amplification of the IS6110 Target Sequences 
All isolates were subjected to PCR, that showed a band typical in size (123 
bp) to the target gene (IS 6110) as indicated by the standard DNA 
marker.(Fig 6) 
 
 
 
(Figure 6). The amplicon of IS 6110 gene (123bp) on agrose gel after 
stained with ethidium bromide. lane 1 MW marker, lane 2 control negative, 
lane (3,,4,5,6,7,8,9,10,11,12and 13) patients samples showing positive 
results for IS  6110 gene. 
3.3.2 Detection of katG Gene and kasA in isoniazed 
Out of 123 isolates the resistant strains were 45 (18%), 42(93.3%) gave band 
typical in size to the target gene kat G(209bp) and  as indicated by standard  
DNA ladder  for the presence of isoniazed resistant gene.(Fig 7) isoniazied 
resistants gene kas gene was positive in 5 strain indicating resistance .(Fig 8)   
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(Figure 7). The amplicon of katGgene (209bp) on agrose gel after staining 
with ethidium bromide. Lane 1 MW marker, lane 2 control negative, lane 
(3,,4,7,8,9,10,11 and 12) patients samples showing positive results for katG 
isoniazed resistance gene. 
 
 
 
(Figure 8). The amplicon of kasAGgene (1389bp) on agrose gel after it was 
stained with ethidium bromide. Lane 1 MW marker, lane 2 control negative, 
lane (3,,4,5,6 and 7) patients samples showing positive results for kasA 
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isoniazed resistance gene. Out of 123 isolates the resistant strains were 45 
(18%), only 5(11.1%) gave band typical in size to the target gene kasA. 
3.3.2 Detection of rpoB Gene  
Forty three isolates (95.5%) gave band typical in size to the target gene 
rpoB(158bp) as indicated by standard  DNA ladder  for the presence of 
rifampicin resistacet gene. 
 
Figure 9. The amplicon of rpoB gene (158bp) on agrose gel after staining 
with ethidium bromide. Lane 1 MW marker, lane 3 and 4 control negative,  
lane (2,5,6,7,8,9,10,11 and 12) patients samples showing positive results for  
rifampicin resistant gene. 
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Chapter Four 
Discussions 
4.1 Discussions 
One third of all human beings around the world are infected with M. 
tuberculosis. Due to primary infection or reactivation, more than 80 million 
new cases occurred during the nineties. Moreover, with more than 30 million 
deaths in this decade, tuberculosis is still the major killer among all 
infectious diseases (Schaberg 1996) 
The aim of the present study was to isolate and identify M. tuberculosis 
among tuberculosis patients in Khartoum State and to check the presence of 
rifampicin resistance gene (rpoB) and isoniazed resistance gene (katG and 
kasA) among multi-drug resistant isolates.  Also to evaluate the usefulness 
of PCR as a confirmatory test for detection of M. tuberculosis among 
suspected individual. 
In the present study results of ZN smears showed low sensitivity for the 
diagnosis of pulmonary tuberculosis (36.4%), this may be due to the low 
sensitivity of ZN stain to detect AFB which needs more than 5000 bacilli/ml 
(Iqbar et al  2003). This finding agreed with   Kavita Modi et al (2006) who 
found that the sensitivity of smear was 51%. The culture technique 
performed during this study  to all samples, that showed that (49.2%) culture 
positive while 127(50.8%)were negative, This could be due to the presence 
of nonviable mycobacteria in the samples as some of the subjects were 
receiving anti tubercular treatment or due to the dilution during the 
decontamination processes. 
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In respect of the sensetivity test, the percentage of multidrug resistant 
reflects (18%) serious and alarming to the critical situation of MDR in 
Khartoum state. In the current study the MDR among new cases were 
(9.2%).and this finding in agreement with Ibarhim 2011who found the MDR 
among the new cases was (7.7%).  
All  MDR isolates that showed resistance 45 (18%) were subjected to PCR  
to detect  resistant genes associated with mutation such as (rpoB) gene 
which refer to rifampcin resistance  and (katG and kasA) gene to indicate 
resistance to isoniazid . Isolates that showed positive results to rpoB gene 
were 43 (95.5%)  ,katG 42(93.3%)  and kasA 5(11.1%) . These resultS were 
similar to the drug susceptibility test so rpoB can be used as surrogate 
marker to detect The MDR. These results disagree with Azar et al (2005) 
who found isolates of M. tuberculosis, tested by PCR for rifampicin resistant 
gene (rpoB) showed positive results to rpoB gene 6(7.5%), while 5(6.25%) 
for isoniazed resistance gene (katG) .These findings disagree with Azar et 
al(2009) whose results indicated that 6(7.5%) of rifampicin and 5(6.25%) of 
isoniazed _resistant M. tuberculosis strains isolated in  had rpoB and katG 
mutations. These results are in  agreement with  Zaker et al (2008), who 
found the mutations in isoniazed -resistance-determining region of the  kat G 
gene in their study  isoniazid-resistant isolates were found in 30-90% ,In 
another study by Mariam et al (2001)they found the mutation in rpoB gene 
were identified in 32(93% )from forty-six clinical isolates of M. 
tuberculosis, and  Maria et al (2000)  results showed that, 56 isolates 
multidrug-resistant Mycobacterium tuberculosis from which , 32(88.8%) 
isolates had mutations in the rpoB gene and kat G gene.  
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4.2 Conclusion 
  The study concluded that:  
       1. Multi-drug resistant tuberculosis increased in Sudan, that my results 
to a mixture of physician error and patient non-compliance during treatment. 
       2. PCR is rapid and sensitive tool. Can be used to identify the MDR-
tuberculosis. 
      3. High percentage of mutation in isoniazid associated with  katG gene is 
prominent rather than kasA gene is low.   
  4.3 Recommendation    
1- All diagnosis of TB should pass through conventional methods. 
2- To perform PCR, primers for all suspected lung pathogens should be 
included. 
3- 3. PCR assay should be introduced as diagnostic tool for Tuberculosis 
in order to achieve universal access to high-quality diagnosis and 
patient treatmentand support the development of new tools and enable 
their  effective use. 
4- PCR reducing the possibility of contaminating other specimens. Time, 
labor and cost is minimized, while user safety and test reliability are 
maximized. 
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Appendix (I) 
1. Ziehl-Neelsen Staining: 
1.1 3% Fuchcin 
Basic Fuchcin…………………………………… 3.0g 
95% Ethanol………………………………………100ml      soln.1 
1.2 Phenol 
Phenol crystals……………………………………5.0g 
Distilled water…………………………………… 100ml…..soln.2 
                       (Gentle heat may be required) 
Working Solution: 
Combine 10ml of soln.1 with 90ml of soln.2 and store in an amber bottle at  
R.T. for 6-12 months and filter before use. 
1.3 Decolorizing agent: 25% sulphuric acid  
Conc. Sulphuric acid ………………………………25ml 
Distilled water…………………………………….75ml 
Carefully add conc. Sulphuric acid to water, store at room temperature   for 
6-12 months. 
1.4Counter stain: 0.3% Methylene Blue  
Methylene blue………………………………….0.3g 
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Distilled water…………………………………..100ml 
Store in an amber bottle at R.T. for 6-12 months. 
Appendix (II) 
  Preparation of media (Lowenstein-Jensen Egg medium)Fresh, antibiotic 
free eggs were cleaned by scrubbing with a hand brush in a soap solution, 
rinsed through running water and soaked in ethanol 70%for 15 minutes. 
Hands were washed and scrubbed well before processing. Eggs were 
breaked and transferred in to sterile flask, blindered in sterile mug and 
filtered through four layers of sterile gauze into graduated cylinder. A 
mineral salts solution was prepared by dissolving:- 
Monopotassium phosphate (anhydrous)……………………………..2.4g 
Magnesium sulfate…………………………………………………….24g 
Magnesium citrate…………………………………………………....0.6g 
Asparagine …………………………………………………………..3.6g  
Sterile distilled water ………………………………………………600ml   
The solution was dissolved in water bath 1000C for 45 minutes, cooled to 
room temperature .Then:- 
Malachite green (2%)………………………………………………20 ml 
Glycerol…………………………………………………………….12ml  
Homogenized whole eggs………………………………………..1000ml 
Were added. The complete medium was poured into sterile funnel and 
6to8ml was dispensed into sterile universal bottles, slanted, coagulated by 
inspissation at 850C for 45 minutes .A random sample of each patch was 
incubated at 370C for 48hour for sterility checking. 
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APPENDIX  (III) 
 
Decontamination Of Sputum 
1.Materials and equipments : 
4% NaoH (w/v) autoclaved at 121°C for 15 min. 
distilled water autoclaved at 121°C for 15 min. 
Hcl 8.3 + 1.7 D.W + 0.1 phenolized indicator …………….. 100 ml Hcl / 1 
N 
Screw-capped plastic sterile containers. 
Vortex 
2. NaOH  
4g of NaOH was dissolved in100 ml of distilled water and autoclaved to 
sterilization. 
3. N HCL 
110ml of distilled water was added to 10ml of HCL 37 %( 1N) precaution 
was followed, autoclaved at 1210C for 15 minutes, and stored at room 
temperature. 
APPENDIX(IV)
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Catalase Test 
 Phosphate buffer solution (PBS):pH7  
9.47g of anhydrous Na2HPO4 was dissolved in 1000ml of distilled water to 
make0.067M disodium phosphate (solution 1). 9.07gof monopotassium 
phosphate KH2PO4 was dissolved in 1000ml distilled water to make 0.067M 
monopotassium phosphate (solution 2). To prepare pH6.8buffer solution 
50ml of solution 1 was mixed with 50ml of solution 2 and checked on PH 
meter, if the final buffer requires adjustment, solution 1 was added to raise 
the PH or solution 2 to lower it. 
 
APPENDIX  (V) 
 Tween reagent 10% Tween 80  
  10ml of tween 80 was mixed with 90ml distilled water. Autoclaved at 
1210c for 10 minutes, immediately the solution was swirled after autoclaving 
and during cooling to resolubilize tween and stored at 50C. 
6. Tween80-hydrogen peroxide mixture 
Equal parts of 10% tween 80 solution and 30%hydrogen peroxide were 
mixed just before use. Precautions were taken when handling superoxol 
 
APPENDIX  (VI) 
 Nitrate substrate solution 
0.085g NaNO3,0.117g KH2PO4, 0.485gNa2HPO4, 12H2O were dissolved 
in 100ml of distilled water to prepare 0.01 M sodium nitrate in 0.002 M 
PBS, pH 7.0 and sterilized by autoclaving.  
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APPENDIX  (VII) 
 Lame Reagent 
One part of N-1-naphthylethylene-diamine dihydrochlorid,one part of 
sulphanilic acid and ten part of tartaric acid 
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